JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2233024, encodeId=bd502233024a9, content=这个杂志已被on hold，不要再投稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Fri Oct 25 05:47:36 CST 2024, time=2024-10-25, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=1193071, encodeId=043811930e1cd, content=请问这个怎么交版面费啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1c165578466, createdName=ms7000001823033593, createdTime=Sun Feb 13 20:32:23 CST 2022, time=2022-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122202, encodeId=a5b6212220231, content=有人知道JBRHA杂志大修后多久能给结果么，焦虑中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40de2862236, createdName=007lancet, createdTime=Tue Mar 28 09:16:10 CST 2023, time=2023-03-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1183146, encodeId=7f381183146c1, content=从杂志主页找到的投稿邮箱，piocontieditor@biolifesas.org，结果投稿一周多了，没有收到任何回执，连是否投稿成功都不知道，请问投稿后有收到邮件确认投稿成功么？请问各位大神有没有类似情况的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=460045201, createdName=ruoshui0429, createdTime=Tue Jan 11 11:09:10 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060828, encodeId=366e10608281a, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：抗种瘤 经验分享：想问一下，这家期刊投稿的方式是用邮箱投稿吗？不是在官网上传文件。这是我的投稿网址，说用邮箱投稿。发邮件投稿，一周编辑就回复我了http://www.biolifesas.org/biolife/category/journals/journal-of-biological-regulators-and-homeostatic-agents/, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201225/cd5495326820459b9d3472b146caf29d/5bd3aeede03f4ffbad591089f25ee0ce.jpg, createdBy=12475361675, createdName=ms68733120959934896309, createdTime=Fri Oct 15 19:39:27 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092597, encodeId=3f57109259eb6, content=researcharticle有哪几大块组成？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092598, encodeId=a76c109259830, content=实验大概做到什么阶段动手写文章比较合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814389, encodeId=d706814389c0, content=请问有没有投稿连接或杂志主页呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d0a2283745, createdName=121cf329m33暂无昵称, createdTime=Fri Aug 28 00:15:56 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541133, encodeId=6088541133c3, content=有点惨淡，这1.5分都保不住，日子怎么过？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=426, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yumi_123, createdTime=Fri Jul 14 18:45:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509728, encodeId=42d3509e2877, content=找不到这个杂志的主页呢，各位有链接吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cf5c1614735, createdName=cherryyixue, createdTime=Tue Feb 10 09:26:00 CST 2015, time=2015-02-10, status=1, ipAttribution=)]

2024-10-25 侠胆医心来自威斯康星

这个杂志已被on hold，不要再投稿了

20 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2233024, encodeId=bd502233024a9, content=这个杂志已被on hold，不要再投稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Fri Oct 25 05:47:36 CST 2024, time=2024-10-25, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=1193071, encodeId=043811930e1cd, content=请问这个怎么交版面费啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1c165578466, createdName=ms7000001823033593, createdTime=Sun Feb 13 20:32:23 CST 2022, time=2022-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122202, encodeId=a5b6212220231, content=有人知道JBRHA杂志大修后多久能给结果么，焦虑中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40de2862236, createdName=007lancet, createdTime=Tue Mar 28 09:16:10 CST 2023, time=2023-03-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1183146, encodeId=7f381183146c1, content=从杂志主页找到的投稿邮箱，piocontieditor@biolifesas.org，结果投稿一周多了，没有收到任何回执，连是否投稿成功都不知道，请问投稿后有收到邮件确认投稿成功么？请问各位大神有没有类似情况的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=460045201, createdName=ruoshui0429, createdTime=Tue Jan 11 11:09:10 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060828, encodeId=366e10608281a, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：抗种瘤 经验分享：想问一下，这家期刊投稿的方式是用邮箱投稿吗？不是在官网上传文件。这是我的投稿网址，说用邮箱投稿。发邮件投稿，一周编辑就回复我了http://www.biolifesas.org/biolife/category/journals/journal-of-biological-regulators-and-homeostatic-agents/, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201225/cd5495326820459b9d3472b146caf29d/5bd3aeede03f4ffbad591089f25ee0ce.jpg, createdBy=12475361675, createdName=ms68733120959934896309, createdTime=Fri Oct 15 19:39:27 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092597, encodeId=3f57109259eb6, content=researcharticle有哪几大块组成？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092598, encodeId=a76c109259830, content=实验大概做到什么阶段动手写文章比较合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814389, encodeId=d706814389c0, content=请问有没有投稿连接或杂志主页呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d0a2283745, createdName=121cf329m33暂无昵称, createdTime=Fri Aug 28 00:15:56 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541133, encodeId=6088541133c3, content=有点惨淡，这1.5分都保不住，日子怎么过？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=426, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yumi_123, createdTime=Fri Jul 14 18:45:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509728, encodeId=42d3509e2877, content=找不到这个杂志的主页呢，各位有链接吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cf5c1614735, createdName=cherryyixue, createdTime=Tue Feb 10 09:26:00 CST 2015, time=2015-02-10, status=1, ipAttribution=)]

2022-02-13 ms7000001823033593

请问这个怎么交版面费啊？

82 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2233024, encodeId=bd502233024a9, content=这个杂志已被on hold，不要再投稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Fri Oct 25 05:47:36 CST 2024, time=2024-10-25, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=1193071, encodeId=043811930e1cd, content=请问这个怎么交版面费啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1c165578466, createdName=ms7000001823033593, createdTime=Sun Feb 13 20:32:23 CST 2022, time=2022-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122202, encodeId=a5b6212220231, content=有人知道JBRHA杂志大修后多久能给结果么，焦虑中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40de2862236, createdName=007lancet, createdTime=Tue Mar 28 09:16:10 CST 2023, time=2023-03-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1183146, encodeId=7f381183146c1, content=从杂志主页找到的投稿邮箱，piocontieditor@biolifesas.org，结果投稿一周多了，没有收到任何回执，连是否投稿成功都不知道，请问投稿后有收到邮件确认投稿成功么？请问各位大神有没有类似情况的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=460045201, createdName=ruoshui0429, createdTime=Tue Jan 11 11:09:10 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060828, encodeId=366e10608281a, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：抗种瘤 经验分享：想问一下，这家期刊投稿的方式是用邮箱投稿吗？不是在官网上传文件。这是我的投稿网址，说用邮箱投稿。发邮件投稿，一周编辑就回复我了http://www.biolifesas.org/biolife/category/journals/journal-of-biological-regulators-and-homeostatic-agents/, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201225/cd5495326820459b9d3472b146caf29d/5bd3aeede03f4ffbad591089f25ee0ce.jpg, createdBy=12475361675, createdName=ms68733120959934896309, createdTime=Fri Oct 15 19:39:27 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092597, encodeId=3f57109259eb6, content=researcharticle有哪几大块组成？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092598, encodeId=a76c109259830, content=实验大概做到什么阶段动手写文章比较合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814389, encodeId=d706814389c0, content=请问有没有投稿连接或杂志主页呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d0a2283745, createdName=121cf329m33暂无昵称, createdTime=Fri Aug 28 00:15:56 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541133, encodeId=6088541133c3, content=有点惨淡，这1.5分都保不住，日子怎么过？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=426, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yumi_123, createdTime=Fri Jul 14 18:45:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509728, encodeId=42d3509e2877, content=找不到这个杂志的主页呢，各位有链接吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cf5c1614735, createdName=cherryyixue, createdTime=Tue Feb 10 09:26:00 CST 2015, time=2015-02-10, status=1, ipAttribution=)]

2023-03-28 007lancet 来自北京

有人知道JBRHA杂志大修后多久能给结果么，焦虑中

69 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2233024, encodeId=bd502233024a9, content=这个杂志已被on hold，不要再投稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Fri Oct 25 05:47:36 CST 2024, time=2024-10-25, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=1193071, encodeId=043811930e1cd, content=请问这个怎么交版面费啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1c165578466, createdName=ms7000001823033593, createdTime=Sun Feb 13 20:32:23 CST 2022, time=2022-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122202, encodeId=a5b6212220231, content=有人知道JBRHA杂志大修后多久能给结果么，焦虑中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40de2862236, createdName=007lancet, createdTime=Tue Mar 28 09:16:10 CST 2023, time=2023-03-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1183146, encodeId=7f381183146c1, content=从杂志主页找到的投稿邮箱，piocontieditor@biolifesas.org，结果投稿一周多了，没有收到任何回执，连是否投稿成功都不知道，请问投稿后有收到邮件确认投稿成功么？请问各位大神有没有类似情况的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=460045201, createdName=ruoshui0429, createdTime=Tue Jan 11 11:09:10 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060828, encodeId=366e10608281a, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：抗种瘤 经验分享：想问一下，这家期刊投稿的方式是用邮箱投稿吗？不是在官网上传文件。这是我的投稿网址，说用邮箱投稿。发邮件投稿，一周编辑就回复我了http://www.biolifesas.org/biolife/category/journals/journal-of-biological-regulators-and-homeostatic-agents/, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201225/cd5495326820459b9d3472b146caf29d/5bd3aeede03f4ffbad591089f25ee0ce.jpg, createdBy=12475361675, createdName=ms68733120959934896309, createdTime=Fri Oct 15 19:39:27 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092597, encodeId=3f57109259eb6, content=researcharticle有哪几大块组成？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092598, encodeId=a76c109259830, content=实验大概做到什么阶段动手写文章比较合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814389, encodeId=d706814389c0, content=请问有没有投稿连接或杂志主页呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d0a2283745, createdName=121cf329m33暂无昵称, createdTime=Fri Aug 28 00:15:56 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541133, encodeId=6088541133c3, content=有点惨淡，这1.5分都保不住，日子怎么过？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=426, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yumi_123, createdTime=Fri Jul 14 18:45:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509728, encodeId=42d3509e2877, content=找不到这个杂志的主页呢，各位有链接吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cf5c1614735, createdName=cherryyixue, createdTime=Tue Feb 10 09:26:00 CST 2015, time=2015-02-10, status=1, ipAttribution=)]

2022-01-11 ruoshui0429

从杂志主页找到的投稿邮箱，piocontieditor@biolifesas.org，结果投稿一周多了，没有收到任何回执，连是否投稿成功都不知道，请问投稿后有收到邮件确认投稿成功么？请问各位大神有没有类似情况的？

88 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2233024, encodeId=bd502233024a9, content=这个杂志已被on hold，不要再投稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Fri Oct 25 05:47:36 CST 2024, time=2024-10-25, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=1193071, encodeId=043811930e1cd, content=请问这个怎么交版面费啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1c165578466, createdName=ms7000001823033593, createdTime=Sun Feb 13 20:32:23 CST 2022, time=2022-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122202, encodeId=a5b6212220231, content=有人知道JBRHA杂志大修后多久能给结果么，焦虑中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40de2862236, createdName=007lancet, createdTime=Tue Mar 28 09:16:10 CST 2023, time=2023-03-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1183146, encodeId=7f381183146c1, content=从杂志主页找到的投稿邮箱，piocontieditor@biolifesas.org，结果投稿一周多了，没有收到任何回执，连是否投稿成功都不知道，请问投稿后有收到邮件确认投稿成功么？请问各位大神有没有类似情况的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=460045201, createdName=ruoshui0429, createdTime=Tue Jan 11 11:09:10 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060828, encodeId=366e10608281a, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：抗种瘤 经验分享：想问一下，这家期刊投稿的方式是用邮箱投稿吗？不是在官网上传文件。这是我的投稿网址，说用邮箱投稿。发邮件投稿，一周编辑就回复我了http://www.biolifesas.org/biolife/category/journals/journal-of-biological-regulators-and-homeostatic-agents/, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201225/cd5495326820459b9d3472b146caf29d/5bd3aeede03f4ffbad591089f25ee0ce.jpg, createdBy=12475361675, createdName=ms68733120959934896309, createdTime=Fri Oct 15 19:39:27 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092597, encodeId=3f57109259eb6, content=researcharticle有哪几大块组成？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092598, encodeId=a76c109259830, content=实验大概做到什么阶段动手写文章比较合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814389, encodeId=d706814389c0, content=请问有没有投稿连接或杂志主页呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d0a2283745, createdName=121cf329m33暂无昵称, createdTime=Fri Aug 28 00:15:56 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541133, encodeId=6088541133c3, content=有点惨淡，这1.5分都保不住，日子怎么过？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=426, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yumi_123, createdTime=Fri Jul 14 18:45:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509728, encodeId=42d3509e2877, content=找不到这个杂志的主页呢，各位有链接吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cf5c1614735, createdName=cherryyixue, createdTime=Tue Feb 10 09:26:00 CST 2015, time=2015-02-10, status=1, ipAttribution=)]

2021-10-15 ms68733120959934896309

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：抗种瘤
经验分享：想问一下，这家期刊投稿的方式是用邮箱投稿吗？不是在官网上传文件。这是我的投稿网址，说用邮箱投稿。发邮件投稿，一周编辑就回复我了http://www.biolifesas.org/biolife/category/journals/journal-of-biological-regulators-and-homeostatic-agents/

101 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2233024, encodeId=bd502233024a9, content=这个杂志已被on hold，不要再投稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Fri Oct 25 05:47:36 CST 2024, time=2024-10-25, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=1193071, encodeId=043811930e1cd, content=请问这个怎么交版面费啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1c165578466, createdName=ms7000001823033593, createdTime=Sun Feb 13 20:32:23 CST 2022, time=2022-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122202, encodeId=a5b6212220231, content=有人知道JBRHA杂志大修后多久能给结果么，焦虑中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40de2862236, createdName=007lancet, createdTime=Tue Mar 28 09:16:10 CST 2023, time=2023-03-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1183146, encodeId=7f381183146c1, content=从杂志主页找到的投稿邮箱，piocontieditor@biolifesas.org，结果投稿一周多了，没有收到任何回执，连是否投稿成功都不知道，请问投稿后有收到邮件确认投稿成功么？请问各位大神有没有类似情况的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=460045201, createdName=ruoshui0429, createdTime=Tue Jan 11 11:09:10 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060828, encodeId=366e10608281a, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：抗种瘤 经验分享：想问一下，这家期刊投稿的方式是用邮箱投稿吗？不是在官网上传文件。这是我的投稿网址，说用邮箱投稿。发邮件投稿，一周编辑就回复我了http://www.biolifesas.org/biolife/category/journals/journal-of-biological-regulators-and-homeostatic-agents/, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201225/cd5495326820459b9d3472b146caf29d/5bd3aeede03f4ffbad591089f25ee0ce.jpg, createdBy=12475361675, createdName=ms68733120959934896309, createdTime=Fri Oct 15 19:39:27 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092597, encodeId=3f57109259eb6, content=researcharticle有哪几大块组成？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092598, encodeId=a76c109259830, content=实验大概做到什么阶段动手写文章比较合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814389, encodeId=d706814389c0, content=请问有没有投稿连接或杂志主页呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d0a2283745, createdName=121cf329m33暂无昵称, createdTime=Fri Aug 28 00:15:56 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541133, encodeId=6088541133c3, content=有点惨淡，这1.5分都保不住，日子怎么过？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=426, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yumi_123, createdTime=Fri Jul 14 18:45:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509728, encodeId=42d3509e2877, content=找不到这个杂志的主页呢，各位有链接吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cf5c1614735, createdName=cherryyixue, createdTime=Tue Feb 10 09:26:00 CST 2015, time=2015-02-10, status=1, ipAttribution=)]

2021-12-27 Gym璨烨

researcharticle有哪几大块组成？

109 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2233024, encodeId=bd502233024a9, content=这个杂志已被on hold，不要再投稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Fri Oct 25 05:47:36 CST 2024, time=2024-10-25, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=1193071, encodeId=043811930e1cd, content=请问这个怎么交版面费啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1c165578466, createdName=ms7000001823033593, createdTime=Sun Feb 13 20:32:23 CST 2022, time=2022-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122202, encodeId=a5b6212220231, content=有人知道JBRHA杂志大修后多久能给结果么，焦虑中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40de2862236, createdName=007lancet, createdTime=Tue Mar 28 09:16:10 CST 2023, time=2023-03-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1183146, encodeId=7f381183146c1, content=从杂志主页找到的投稿邮箱，piocontieditor@biolifesas.org，结果投稿一周多了，没有收到任何回执，连是否投稿成功都不知道，请问投稿后有收到邮件确认投稿成功么？请问各位大神有没有类似情况的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=460045201, createdName=ruoshui0429, createdTime=Tue Jan 11 11:09:10 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060828, encodeId=366e10608281a, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：抗种瘤 经验分享：想问一下，这家期刊投稿的方式是用邮箱投稿吗？不是在官网上传文件。这是我的投稿网址，说用邮箱投稿。发邮件投稿，一周编辑就回复我了http://www.biolifesas.org/biolife/category/journals/journal-of-biological-regulators-and-homeostatic-agents/, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201225/cd5495326820459b9d3472b146caf29d/5bd3aeede03f4ffbad591089f25ee0ce.jpg, createdBy=12475361675, createdName=ms68733120959934896309, createdTime=Fri Oct 15 19:39:27 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092597, encodeId=3f57109259eb6, content=researcharticle有哪几大块组成？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092598, encodeId=a76c109259830, content=实验大概做到什么阶段动手写文章比较合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814389, encodeId=d706814389c0, content=请问有没有投稿连接或杂志主页呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d0a2283745, createdName=121cf329m33暂无昵称, createdTime=Fri Aug 28 00:15:56 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541133, encodeId=6088541133c3, content=有点惨淡，这1.5分都保不住，日子怎么过？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=426, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yumi_123, createdTime=Fri Jul 14 18:45:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509728, encodeId=42d3509e2877, content=找不到这个杂志的主页呢，各位有链接吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cf5c1614735, createdName=cherryyixue, createdTime=Tue Feb 10 09:26:00 CST 2015, time=2015-02-10, status=1, ipAttribution=)]

2021-12-27 rayms

实验大概做到什么阶段动手写文章比较合适？

96 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2233024, encodeId=bd502233024a9, content=这个杂志已被on hold，不要再投稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Fri Oct 25 05:47:36 CST 2024, time=2024-10-25, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=1193071, encodeId=043811930e1cd, content=请问这个怎么交版面费啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1c165578466, createdName=ms7000001823033593, createdTime=Sun Feb 13 20:32:23 CST 2022, time=2022-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122202, encodeId=a5b6212220231, content=有人知道JBRHA杂志大修后多久能给结果么，焦虑中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40de2862236, createdName=007lancet, createdTime=Tue Mar 28 09:16:10 CST 2023, time=2023-03-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1183146, encodeId=7f381183146c1, content=从杂志主页找到的投稿邮箱，piocontieditor@biolifesas.org，结果投稿一周多了，没有收到任何回执，连是否投稿成功都不知道，请问投稿后有收到邮件确认投稿成功么？请问各位大神有没有类似情况的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=460045201, createdName=ruoshui0429, createdTime=Tue Jan 11 11:09:10 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060828, encodeId=366e10608281a, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：抗种瘤 经验分享：想问一下，这家期刊投稿的方式是用邮箱投稿吗？不是在官网上传文件。这是我的投稿网址，说用邮箱投稿。发邮件投稿，一周编辑就回复我了http://www.biolifesas.org/biolife/category/journals/journal-of-biological-regulators-and-homeostatic-agents/, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201225/cd5495326820459b9d3472b146caf29d/5bd3aeede03f4ffbad591089f25ee0ce.jpg, createdBy=12475361675, createdName=ms68733120959934896309, createdTime=Fri Oct 15 19:39:27 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092597, encodeId=3f57109259eb6, content=researcharticle有哪几大块组成？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092598, encodeId=a76c109259830, content=实验大概做到什么阶段动手写文章比较合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814389, encodeId=d706814389c0, content=请问有没有投稿连接或杂志主页呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d0a2283745, createdName=121cf329m33暂无昵称, createdTime=Fri Aug 28 00:15:56 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541133, encodeId=6088541133c3, content=有点惨淡，这1.5分都保不住，日子怎么过？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=426, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yumi_123, createdTime=Fri Jul 14 18:45:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509728, encodeId=42d3509e2877, content=找不到这个杂志的主页呢，各位有链接吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cf5c1614735, createdName=cherryyixue, createdTime=Tue Feb 10 09:26:00 CST 2015, time=2015-02-10, status=1, ipAttribution=)]

2020-08-28 121cf329m33暂无昵称

请问有没有投稿连接或杂志主页呢

180 0

[GetPortalCommentsPageByObjectIdResponse(id=2233024, encodeId=bd502233024a9, content=这个杂志已被on hold，不要再投稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Fri Oct 25 05:47:36 CST 2024, time=2024-10-25, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=1193071, encodeId=043811930e1cd, content=请问这个怎么交版面费啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1c165578466, createdName=ms7000001823033593, createdTime=Sun Feb 13 20:32:23 CST 2022, time=2022-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122202, encodeId=a5b6212220231, content=有人知道JBRHA杂志大修后多久能给结果么，焦虑中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40de2862236, createdName=007lancet, createdTime=Tue Mar 28 09:16:10 CST 2023, time=2023-03-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1183146, encodeId=7f381183146c1, content=从杂志主页找到的投稿邮箱，piocontieditor@biolifesas.org，结果投稿一周多了，没有收到任何回执，连是否投稿成功都不知道，请问投稿后有收到邮件确认投稿成功么？请问各位大神有没有类似情况的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=460045201, createdName=ruoshui0429, createdTime=Tue Jan 11 11:09:10 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060828, encodeId=366e10608281a, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：抗种瘤 经验分享：想问一下，这家期刊投稿的方式是用邮箱投稿吗？不是在官网上传文件。这是我的投稿网址，说用邮箱投稿。发邮件投稿，一周编辑就回复我了http://www.biolifesas.org/biolife/category/journals/journal-of-biological-regulators-and-homeostatic-agents/, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201225/cd5495326820459b9d3472b146caf29d/5bd3aeede03f4ffbad591089f25ee0ce.jpg, createdBy=12475361675, createdName=ms68733120959934896309, createdTime=Fri Oct 15 19:39:27 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092597, encodeId=3f57109259eb6, content=researcharticle有哪几大块组成？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092598, encodeId=a76c109259830, content=实验大概做到什么阶段动手写文章比较合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814389, encodeId=d706814389c0, content=请问有没有投稿连接或杂志主页呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d0a2283745, createdName=121cf329m33暂无昵称, createdTime=Fri Aug 28 00:15:56 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541133, encodeId=6088541133c3, content=有点惨淡，这1.5分都保不住，日子怎么过？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=426, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yumi_123, createdTime=Fri Jul 14 18:45:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509728, encodeId=42d3509e2877, content=找不到这个杂志的主页呢，各位有链接吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cf5c1614735, createdName=cherryyixue, createdTime=Tue Feb 10 09:26:00 CST 2015, time=2015-02-10, status=1, ipAttribution=)]

2017-07-14 yumi_123

有点惨淡，这1.5分都保不住，日子怎么过？？

426 0

[GetPortalCommentsPageByObjectIdResponse(id=2233024, encodeId=bd502233024a9, content=这个杂志已被on hold，不要再投稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Fri Oct 25 05:47:36 CST 2024, time=2024-10-25, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=1193071, encodeId=043811930e1cd, content=请问这个怎么交版面费啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1c165578466, createdName=ms7000001823033593, createdTime=Sun Feb 13 20:32:23 CST 2022, time=2022-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122202, encodeId=a5b6212220231, content=有人知道JBRHA杂志大修后多久能给结果么，焦虑中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40de2862236, createdName=007lancet, createdTime=Tue Mar 28 09:16:10 CST 2023, time=2023-03-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1183146, encodeId=7f381183146c1, content=从杂志主页找到的投稿邮箱，piocontieditor@biolifesas.org，结果投稿一周多了，没有收到任何回执，连是否投稿成功都不知道，请问投稿后有收到邮件确认投稿成功么？请问各位大神有没有类似情况的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=460045201, createdName=ruoshui0429, createdTime=Tue Jan 11 11:09:10 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060828, encodeId=366e10608281a, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：抗种瘤 经验分享：想问一下，这家期刊投稿的方式是用邮箱投稿吗？不是在官网上传文件。这是我的投稿网址，说用邮箱投稿。发邮件投稿，一周编辑就回复我了http://www.biolifesas.org/biolife/category/journals/journal-of-biological-regulators-and-homeostatic-agents/, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201225/cd5495326820459b9d3472b146caf29d/5bd3aeede03f4ffbad591089f25ee0ce.jpg, createdBy=12475361675, createdName=ms68733120959934896309, createdTime=Fri Oct 15 19:39:27 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092597, encodeId=3f57109259eb6, content=researcharticle有哪几大块组成？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092598, encodeId=a76c109259830, content=实验大概做到什么阶段动手写文章比较合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814389, encodeId=d706814389c0, content=请问有没有投稿连接或杂志主页呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d0a2283745, createdName=121cf329m33暂无昵称, createdTime=Fri Aug 28 00:15:56 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541133, encodeId=6088541133c3, content=有点惨淡，这1.5分都保不住，日子怎么过？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=426, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yumi_123, createdTime=Fri Jul 14 18:45:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509728, encodeId=42d3509e2877, content=找不到这个杂志的主页呢，各位有链接吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cf5c1614735, createdName=cherryyixue, createdTime=Tue Feb 10 09:26:00 CST 2015, time=2015-02-10, status=1, ipAttribution=)]

2015-02-10 cherryyixue

找不到这个杂志的主页呢，各位有链接吗？

476 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务